title: Is risk-benefit of warfarin for atrial fibrillation with heart failure determined by heart failure severity?
authors.affiliation: Prof. Andrew Sindone, Department of Cardiology, Concord Hospital, Sydney, NSW 2139, Australia, E-mail: andrew.sindone@email.cs.nsw.gov.au.
authors.forename: Andrew P
authors.initials: AP
authors.lastname: Sindone
authors.forename: S Ben
authors.initials: SB
authors.lastname: Freedman
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001777:Blood Coagulation / Q000187:drug effects*; D002545:Brain Ischemia / Q000517:prevention & control*; D005260:Female; D006333:Heart Failure / Q000150:complications*; D006801:Humans; D008297:Male; D020521:Stroke / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D014859:Warfarin